HAEMATO AG
HAEMATO AG, headquartered in Germany, is a prominent player in the pharmaceutical industry, specialising in the development and distribution of innovative therapies for patients with rare diseases and complex health conditions. Founded in 1993, the company has established a strong presence across Europe, focusing on key operational regions such as Germany and other EU countries. With a commitment to enhancing patient care, HAEMATO AG offers a diverse portfolio of products, including specialty pharmaceuticals and biosimilars, which are distinguished by their high quality and efficacy. The company has achieved significant milestones, positioning itself as a trusted partner in the healthcare sector, known for its dedication to research and development. HAEMATO AG continues to make strides in the market, contributing to advancements in treatment options and improving the lives of patients worldwide.
DitchCarbon Score
How does HAEMATO AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
HAEMATO AG's score of 22 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
HAEMATO AG's reported carbon emissions
HAEMATO AG, headquartered in Germany, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company has not established documented reduction targets or commitments to the Science Based Targets initiative (SBTi) or other climate pledges. As there is no available data on their carbon footprint, it is unclear how HAEMATO AG is addressing climate change or what specific initiatives they may be undertaking in this regard. The lack of emissions reporting suggests that the company may still be in the early stages of developing a comprehensive climate strategy. In the context of the industry, many companies are increasingly focusing on transparency and accountability regarding their carbon emissions, often setting ambitious targets to reduce their environmental impact. However, without specific data or commitments from HAEMATO AG, it is difficult to assess their position relative to industry standards.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
HAEMATO AG is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
